LONDON : A major non-profit health emergencies group has set up a global laboratory network to assess data from potential COVID-19 vaccines, allowing scientists and drugmakers to compare them and speed up selection of the most effective shots.Speaking to Reuters ahead of announcing the labs involved, Melanie Saville, director of vaccine R&D at the Coalition for Epidemic Preparedness Innovations (CEPI), said the idea was to "compare apples with apples" as drugmakers race to develop an effective shot to help control the COVID-19 pandemic.The centralised network is the first of its kind to be set up in response to a pandemic.In a network spanning Europe, Asia and North America, the labs will centralise analysis of samples from trials of.